Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblasti... ( THOUSAND OAKS Calif. May 16 2012 /-&#...)

HOME >> MEDICINE >> TECHNOLOGY

Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Date:5/16/2012

THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced updated results from a Phase 2 study that showed treatment with blinatumomab (AMG 103) helped achieve a high-rate of complete response (CR) in 72 percent of adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL) treated in the study. Blinatumomab is the first of a new class of agents called bi-specific T cell engagers (BiTE®) antibodies, designed to harness the body's cell-destroying T cells to kill cancer cells. Blinatumomab targets cells expressing CD19, a protein found on the surface of B-cell derived leukemias and lymphomas, such as ALL. Full results of the study will be presented during an oral abstract session at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) on June 4 (Abstract Number 6500, 8:00 a.m. - 8:15 a.m. CDT, E354a).

In this Phase 2 single-arm dose-ranging trial, 26 of the 36 patients treated with blinatumomab across all of the tested doses and schedules achieved a CR with partial hematologic recovery (CRh*). All but two patients achieved a molecular response, meaning there was no evidence of leukemic cells by polymerase chain reaction. No treatment related deaths or serious adverse events (AEs) were reported in the study.

At the time of the analysis, median survival was 9.0 (8.2, 15.8) months with a median follow-up period of 10.7 months. In the group of patients who received the selected dose, median survival was 8.5 months. The median duration of response in the 26 patients who responded to treatment was 8.9 months.

"For these patients with limited treatment options, the remission rate observed in the trial is a vast improvement over the current standard of care," said Professor Max Topp, Department of Internal Medicine II, University of Wuerzburg and chair of the study. "These
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
2. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
3. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
7. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
8. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future

Post Your Comments:

(Date:5/20/2013)... , May 20, 2013 Medicare Part D ... overwhelmingly satisfied, citing lower costs, convenient access to ... survey from Hart Research Associates released today by ... 40% of Part D seniors (9.5 million) are ... "Seniors like the lower costs, pharmacy choices, ...

(Date:5/19/2013)... , May 20, 2013 Claret Medical, Inc. ... Nicolas Van Mieghem et al., Histopathology ... Published ahead of print in Circulation, May 7 th ... Medical Center, Rotterdam, the Netherlands and ... of the Cardiovascular Pathology Institute, Gaithersburg, Maryland. ...

(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...

Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2 Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2 New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2 New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3

[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices [0] Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR [0] New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses

... N.J., Oct. 12 Schering-Plough Corporation (NYSE: SGP ) ... the 2009 third quarter on Thursday, Oct. 22, 2009. ... Schering-Plough will conduct a conference call to review results for ... CEO, and other members of management will host the conference ...

... , ANN ARBOR, Mich., Oct. 12 The University ... (®) from Thomson Reuters to provide physicians, nurses, and ... electronic drug dosing, interaction checking, and reference information. ... 575-bed academic medical center that specializes in heart disease, ...

Cached Medicine Technology:Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2 University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 2 University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 3

Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety

(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and ... tips that can help them overcome one of the most ... Natural Vitiligo Treatment System has created a buzz ... has received from the persons who have tried it. Its ... has interviewed some of the people who tried it and ...

(Date:5/20/2013)... 20, 2013 Leading facial plastic surgeon and ... as a “Top Doc” in the field of Otolaryngology in ... , The Palm Beacher magazine, one of Palm Beach County’s ... in the May/June 2013 issue, including 70 of the very ... dining, events, things to do, health and fitness, people to ...

(Date:5/20/2013)... According to a June 2009 Bloomberg article, ... amount to approximately $3.6 billion dollars per year (i). ... estimated that there 15 million incidents of medical harm ... everyone who receives any form of medical treatment should ... Merriam-Webster defines malpractice as “a dereliction of professional duty ...

(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...

(Date:5/20/2013)... VA (PRWEB) May 20, 2013 ... Project , Who: Sloan Gibson, President, USO ... Vice President of Outreach Initiatives and ... Sesame Street , Representatives from:, ... , • ...

Breaking Medicine News(10 mins):Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2 Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2 Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2 Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4

[0] New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine [0] Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine [0] Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases [0] Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP [0] USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill

... comeback. Recently published case series have shown encouraging ... treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome. ... International , authors Jens Kuhn (University of Cologne) ... Cologne) and their co-authors provide an introduction to ...

... ... America , ... MD (Vocus) March 2, 2010 -- As Maryland Gov. Martin O’Malley proposes cutting $123 million ... year 2010, a new study by Dr. Todd Eberly, assistant professor of political science and ...

... ... for the Cure® events across the country. , ... Collegedale, TN (Vocus) March 4, 2010 -- Sunbelt ® is pleased to announce ... , , , , ,“The Sunbelt employees who volunteered and participated in last year’s events had ...

... , ... ... , ... , , ...

... ... ... ... ...

... ... Month, Independence-based preventive health screening provider offers discounted FDA-approved home tests kits for colorectal ... Independence, ... kits for colorectal cancer for a discounted price of $15. Neighborhood screenings can ...

Psychosurgery makes gentle comeback Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children Sunbelt Announces Renewed Commitment to Breast Cancer Awareness KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus Essilor - 2009 Financial Results Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

von Willebrand Factor Antigen von Willebrand Factor Activity (Ristocetin Cofactor)Vivarin VMA & HVA Urine